Approval · Notice of Compliance 27502 · 2022
ORGARAN: Notice of Compliance 27502
Issued January 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27502
- Date
- January 25, 2022
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGARAN | Not yet assigned | — |
Medicinal ingredients
- DANAPAROID SODIUM 1,250 UNIT per ML